NABCOP Conference Presentations 2018 – 2020

ABS Annual Conference, 2018:

1. Treatment patterns for unilateral, non-invasive breast cancer in women diagnosed in England: Data from a population-based cohort. [Oral Presentation]
2. Chemotherapy utilisation in patients aged 50 years and over, diagnosed with invasive early breast cancer in England: Data from a population-based cohort. [Oral Presentation]
3. National uptake of adjuvant radiotherapy for invasive breast cancer, by age: Data from a population-based cohort. [Poster Presentation]

SIOG Conference, 2018:

1. Primary and adjuvant treatment for unilateral DCIS in women aged 70 years in England and Wales. [Poster Presentation]
2. Use of taxane-containing adjuvant chemotherapy regimens among older women with operable early breast cancer. [Poster Presentation]

San Antonio Breast Cancer Research Symposium 2019:

1. The influence of patient fitness on the likelihood of receiving primary surgery in older women with breast cancer: A population based cohort study. [Poster Presentation]

ABS Annual Conference, 2019:

1. Surgery and systemic therapy in older women with early stage triple negative breast cancer (TNBC) in England: A population based cohort study within the National Audit of Breast Cancer in Older Patients (NABCOP). [Oral Presentation]
2. The effect of tumour risk and patient factors on the three-year survival for women with early stage triple negative breast cancer (TNBC) in England and Wales: A population based cohort study within National Audit of Breast Cancer in Older Patients (NABCOP). [Oral Presentation]

PHE Public Health Research and Science Conference, 2020:

1. Construction of the secondary care administrative records frailty (SCARF) index and validation on older women with operable breast cancer in England and Wales. [Oral Presentation]

European Breast Cancer Conference, 2020:

1. Variation in rates of surgery for women with metastatic breast cancer across England and Wales. [Poster Presentation]